BA (Oxon), BM BCh (Oxon), MA (Oxon), MEcon (HK), MPH (HK)
Clinical Assistant Professor
Division of Health Economics, Policy and Management
Dr Chao Quan joined the School of Public Health in 2013, and was appointed Clinical Assistant Professor in 2017. He graduated with a degree in Medicine from the University of Oxford. After his clinical training in London, he specialized in public health and subsequently obtained an MPH with Distinction. He received his BA and MA in Medical Sciences (Infection & Immunity) from the University of Oxford, and his postgraduate degree in Economics from the University of Hong Kong.
His research interest lies in the economic analysis of health care services and health policy. Currently, he examining the economic net value of healthcare services for the 700,000 people with diabetes in Hong Kong. Dr Quan also collaborates with Stanford University and other research institutions across Asia and Europe to investigate the net value gained from improved chronic disease management, such as reducing avoidable admissions and adhering to clinical guidelines.
Dr Quan co-ordinates the Introduction to Health Economics course on the postgraduate public health curriculum. To promote and advance public health education, he helped to develop HKU’s first massive open online course (MOOC), Epidemics, which has enrolled more than 16,000 students since launch.
Dr Quan is an Associate Member of the Hong Kong College of Community Medicine, and an honorary physician attached to the Department of Family Medicine & Primary Healthcare, Queen Mary Hospital.
Quan J, Li TK, Pang H, Choi CH, Siu SC, Tang SY, Wat NM, Woo J, Johnston JM, Leung GM. Diabetes incidence and prevalence in Hong Kong, China during 2006–2014. Diabetic Medicine, 2016. doi: 10.1111/dme.13284 [link]
Tan PH, Tyrrell HE, Gao L, Xu D, Quan J, Gill D, Rai L, Ding Y, Plant G, Chen Y, Xue JZ. Adiponectin receptor signaling on dendritic cells blunts antitumor immunity. Cancer research. 2014 Oct 15;74(20):5711-22.
Quan J, Tan PH, MacDonald A, Friend PJ. Manipulation of indoleamine 2, 3-dioxygenase (IDO) for clinical transplantation: promises and challenges. Expert opinion on biological therapy. 2008 Nov 1;8(11):1705-19.